| John Griffiths Jr, MD | |
|
105 S 90th St, Omaha, NE 68114-3963 | |
| (402) 552-2020 | |
| Not Available |
| Full Name | John Griffiths Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 105 S 90th St, Omaha, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770565715 | NPI | - | NPPES |
| 47080542812 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 11025 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Griffiths Jr, MD 4353 Dodge St, Omaha, NE 68131-2709 Ph: (402) 552-2020 | John Griffiths Jr, MD 105 S 90th St, Omaha, NE 68114-3963 Ph: (402) 552-2020 |
News Archive
Acorda Therapeutics, Inc. today announced that the Company has partnered with Watson Pharma, Inc., a subsidiary of Watson Pharmaceuticals, Inc. to introduce tizanidine hydrochloride capsules, an authorized generic version of ZANAFLEX CAPSULES (tizanidine hydrochloride).
A study revealing high concentrations of arsenic in a sample of King George III's hair is published in this week's issue of The Lancet. The authors believe the presence of arsenic in the King's hair contributed to his unusually severe and prolonged bouts of madness.
Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.
MDA-supported researchers at the University of Washington-Seattle have delivered the gene for the dystrophin protein to all voluntary muscles with a single intravenous injection in mice with Duchenne muscular dystrophy (DMD).
GenVec, Inc. (Nasdaq: GNVC) announced today that data were presented on GenVec's respiratory syncytial virus (RSV) vaccine program at the "Keystone Symposium on Viral Immunity and Host Gene Influence", which is taking place in Keystone, Colorado from March 21-26, 2012.
› Verified 1 days ago
Dr. Hythem Abouodah, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3902 Leavenworth St, Omaha, NE 68105 Phone: 402-559-2020 | |
Camilla Ruth Parson, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 16820 Frances St, Ste 100, Omaha, NE 68130 Phone: 402-933-6600 Fax: 402-933-7123 | |
Dr. Sebastian J Troia, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 515 N 98th St, Omaha, NE 68114 Phone: 402-399-9400 Fax: 402-399-8170 | |
Richard H Legge, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7810 Davenport St, Omaha, NE 68114 Phone: 402-397-1626 Fax: 402-397-1286 | |
Ahmad Halawa, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3902 Leavenworth St, Omaha, NE 68105 Phone: 402-559-3255 | |
Dr. Keegan Anthony Harkins, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3902 Leavenworth St, Omaha, NE 68105 Phone: 402-559-2020 | |
Anas L F Yasin, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 985540 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-1859 |